HERCULES, Calif.--(BUSINESS WIRE)--Eureka Genomics announced today the ability to generate high quality, high-throughput sequencing data, using genomic DNA samples that are one thousand-fold less than recommended by sequencing platform developers. This enables, for the first time, access to a service for the sequencing of genomic material from very small amounts and isolates of rare, often irreplaceable, complex clinical, environmental or forensic samples, as well as from difficult to culture microorganisms.
